Genotyping KRAS and EGFR Mutations in Greek Patients With Non-small-cell Lung Cancer: Incidence, Significance and Implications for Treatment

Conclusion: The presence of KRAS mutations is an independent negative prognosticator among Greek NSCLC patients and an independent response predictor to first line treatment.

Source: Cancer Genomics and Proteomics - October 27, 2019 Category: Cancer & Oncology Authors: LINARDOU, H., KOTOULA, V., KOUVATSEAS, G., MOUNTZIOS, G., KARAVASILIS, V., SAMANTAS, E., KALOGERA-FOUNTZILA, A., TELEVANTOU, D., PAPADOPOULOU, K., MAVROPOULOU, X., DASKALAKI, E., ZARAMBOUKAS, T., EFSTRATIOU, I., LAMPAKI, S., RALLIS, G., RES, E., SYRIGOS, Tags: Article Source Type: research